Literature DB >> 29611762

(-)-Guaiol regulates autophagic cell death depending on mTOR signaling in NSCLC.

Xiaohui Yang1, Jiabei Zhu2, Jianchun Wu1, Nan Huang3, Zhongqi Cui3, Yingbin Luo1, Fenyong Sun3, Qiuhui Pan2, Yan Li1, Qingyuan Yang3.   

Abstract

(-)-Guaiol, a sesquiterpene alcohol with the guaiane skeleton, has been found in many Chinese medicinal plants and been reported to comprise various guaiane natural products that are well known for their antibacterial activities. Previously, we have shown its antitumor activity by inducing autophagy in NSCLC cells. However, its potential mechanism in inducing autophagy is still under our investigation. Here, data from our western blotting assays showed that, in NSCLC cells, (-)-Guaiol significantly blocked the mTORC2-AKT signaling by suppressing mTOR phosphorylation at serine 2481 (S2481) to induce autophagy, illustrated by the increasing ratio of LC3II/I. Besides, it impaired the mTORC1 signaling by inhibiting the activity of its downstream factors, such as 4E-BP1 and p70 S6K, all of which could obviously rescued by the mTOR activator MHY1485. Afterwards, results from biofunctional assays, including cell survival analysis, colony formation assays and flow cytometry assays, suggested that (-)-Guaiol triggered autophagic cell death by targeting both mTORC1 and mTORC2 signaling pathways. In summary, our studies showed that (-)-Guaiol inhibited the proliferation of NSCLC cells by specifically targeting mTOR signaling pathways, including both mTORC1 and mTORC2 signaling, providing a better therapeutic option for substituting rapamycin in treating NSCLC patients.

Entities:  

Keywords:  (−)-Guaiol; MHY1485; NSCLC; autophagy; cell survival; mTORC1; mTORC2

Mesh:

Substances:

Year:  2018        PMID: 29611762      PMCID: PMC6067839          DOI: 10.1080/15384047.2018.1451277

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  36 in total

Review 1.  Current development of mTOR inhibitors as anticancer agents.

Authors:  Sandrine Faivre; Guido Kroemer; Eric Raymond
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

2.  Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.

Authors:  Meena Jhanwar-Uniyal; John L Gillick; Jayson Neil; Michael Tobias; Zachary E Thwing; Raj Murali
Journal:  Adv Biol Regul       Date:  2014-09-18

3.  Microbial transformation of (-)-guaiol and antibacterial activity of its transformed products.

Authors:  Muhammad Iqbal Choudhary; Iffat Batool; Muhammad Atif; Samreen Hussain
Journal:  J Nat Prod       Date:  2007-03-27       Impact factor: 4.050

4.  A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.

Authors:  A Sekulić; C C Hudson; J L Homme; P Yin; D M Otterness; L M Karnitz; R T Abraham
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

5.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

6.  Phase I and pharmacokinetic study of CCI-779, a novel cytostatic cell-cycle inhibitor, in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors.

Authors:  C J A Punt; J Boni; U Bruntsch; M Peters; C Thielert
Journal:  Ann Oncol       Date:  2003-06       Impact factor: 32.976

7.  Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function.

Authors:  A Pause; G J Belsham; A C Gingras; O Donzé; T A Lin; J C Lawrence; N Sonenberg
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

Review 8.  The role of mTOR in the management of solid tumors: an overview.

Authors:  Alex S Strimpakos; Eleni M Karapanagiotou; M Wasif Saif; Kostas N Syrigos
Journal:  Cancer Treat Rev       Date:  2008-11-14       Impact factor: 12.111

9.  Dramatic suppression of colorectal cancer cell growth by the dual mTORC1 and mTORC2 inhibitor AZD-2014.

Authors:  Hai-zhong Huo; Zhi-yuan Zhou; Bing Wang; Jian Qin; Wen-yong Liu; Yan Gu
Journal:  Biochem Biophys Res Commun       Date:  2013-12-02       Impact factor: 3.575

10.  Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway.

Authors:  Meijuan Chen; Yuhong Du; Min Qui; Mingyan Wang; Kejun Chen; Zhenzhou Huang; Miao Jiang; Fei Xiong; Jianping Chen; Jing Zhou; Fengrong Jiang; Lian Yin; Yuping Tang; Lihong Ye; Zhen Zhan; Jin-Αo Duan; Hai-Αn Fu; Xu Zhang
Journal:  Oncol Rep       Date:  2012-11-09       Impact factor: 3.906

View more
  3 in total

1.  Hexavalent chromium-induced autophagic death of WRL-68 cells is mitigated by aqueous extract of Cuminum cyminum L. seeds.

Authors:  R Mahalakshmi; J Priyanga; B N Vedha Hari; Dipita Bhakta-Guha; Gunjan Guha
Journal:  3 Biotech       Date:  2020-04-04       Impact factor: 2.406

2.  Tumor-suppressing potential of stingless bee propolis in in vitro and in vivo models of differentiated-type gastric adenocarcinoma.

Authors:  Mark Joseph Desamero; Shigeru Kakuta; Yulan Tang; James Kenn Chambers; Kazuyuki Uchida; Maria Amelita Estacio; Cleofas Cervancia; Yuri Kominami; Hideki Ushio; Jun Nakayama; Hiroyuki Nakayama; Shigeru Kyuwa
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

3.  Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma.

Authors:  Yaoying Zeng; Yanbin Pan; Bo Zhang; Yingbin Luo; Jianhui Tian; Yuli Wang; Xudong Ju; Jianchun Wu; Yan Li
Journal:  Med Sci Monit       Date:  2022-07-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.